The Effect of Pomegranate Juice on the Expression of Some Murine UDP-Glucuronosyltransferases Genes

Author(s): Yacoub M. Irshaid*, Ruba Alani, Razan Al-Rawashdeh, Tuqa Al-Ghazawi, Hiba Hijazi, Dana Amara, Amena Hammad, Zaineh M. Shahrure, Mohammad Al-Shhab

Journal Name: Drug Metabolism Letters

Volume 14 , Issue 1 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Food-drug interactions may lead to suppression or induction of drug metabolizing enzymes. Pomegranate is a commonly used fruit in folk medicine all over the world. Data concerning the effect of pomegranate on the activity of UDP-glucuronosyltransferases (UGTs) is scarce.

Objective: The purpose of this work was to investigate the effect of pomegranate juice ingestion on the transcription of ugt2b1, ugt2a3, and ugt1a9 in the liver and small intestine of male mice.

Methods: Pomegranate juice was administered to 10 male mice for 14 days in drinking bottles instead of water. Ten control mice received water in the drinking bottles. On the 15th day, the mice were sacrificed and the liver and the small intestine were removed. The small intestine was divided into 3 parts. Total mRNA was extracted from samples of these specimens, and cDNA was synthesized by quantitative real-time polymerase chain reaction (RT-PCR) using specific primers for each ugt gene.

Results: The ugt1a9 mRNA level was reduced by 2.25-fold in the liver and by 6-, 1.5-, and 3-folds in the first, second and third part of the small intestine, respectively. The ugt2b1 mRNA level in the liver and the third part of the small intestine was not affected, while it was reduced by 3.7- and 3-folds in the first and second parts of the small intestine, respectively. The ugt2a3 mRNA level was not affected in the liver and the 3 parts of the small intestine.

Conclusion: Some ugt mRNA levels may be reduced by the ingestion of pomegranate juice, which may reduce the metabolism of their drug substrates. The consequences may be an accumulation of such drugs in the body and enhanced toxicity.

Keywords: Mice, pomegranate, ugt activity, ugt genes, ugtmRNA, murine-udp, UDP-glucuronosyltransferases.

[1]
Lansky, E.P.; Newman, R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J. Ethnopharmacol., 2007, 109(2), 177-206.
[http://dx.doi.org/10.1016/j.jep.2006.09.006] [PMID: 17157465]
[2]
Jurenka, J.S. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern. Med. Rev., 2008, 13(2), 128-144.
[PMID: 18590349]
[3]
Lansky, E.; Shubert, S.; Neeman, I. Pharmacological and therapeutic properties of pomegranate, Symposium International Sobre El Granado [First International Symposium on the Pomegranate], Orihuela, Spain, 1998, pp. pp. 15-17.
[4]
Noubani, R.A.; Abu Irmaileh, B.E.; Afifi, F.U. Folk Utilization of Traditional Medicinal Plants among Rural Population in Wadi Mujib–Jordan. J Med J, 2006, 40(4), 232-240.
[5]
Al-Mustafa, A.H.; Al-Thunibat, O.Y. Antioxidant activity of some Jordanian medicinal plants used traditionally for treatment of diabetes. Pak. J. Biol. Sci., 2008, 11(3), 351-358.
[http://dx.doi.org/10.3923/pjbs.2008.351.358] [PMID: 18817155]
[6]
Gil, M.I.; Tomás-Barberán, F.A.; Hess-Pierce, B.; Holcroft, D.M.; Kader, A.A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem., 2000, 48(10), 4581-4589.
[http://dx.doi.org/10.1021/jf000404a] [PMID: 11052704]
[7]
Ben Nasr, C.; Ayed, N.; Metche, M. Quantitative determination of the polyphenolic content of pomegranate peel. Z. Lebensm. Unters. Forsch., 1996, 203(4), 374-378.
[http://dx.doi.org/10.1007/BF01231077] [PMID: 9123975]
[8]
Oda, S.; Fukami, T.; Yokoi, T.; Nakajima, M. A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development. Drug Metab. Pharmacokinet., 2015, 30(1), 30-51.
[http://dx.doi.org/10.1016/j.dmpk.2014.12.001] [PMID: 25760529]
[9]
Buckley, D.B.; Klaassen, C.D. Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab. Dispos., 2007, 35(1), 121-127.
[http://dx.doi.org/10.1124/dmd.106.012070] [PMID: 17050650]
[10]
Hodges, R.E.; Minich, D. M. Modulation of metabolic detoxification pathways using foods and food-derived components: A scientific review with clinical application. J Nutr Metab, 2015. Article ID 760689.
[http://dx.doi.org/10.1155/2015/760689]
[11]
MacDonald, L.; Foster, B.C.; Akhtar, H. Food and therapeutic product interactions - a therapeutic perspective. J. Pharm. Pharm. Sci., 2009, 12(3), 367-377.
[http://dx.doi.org/10.18433/J30P4C] [PMID: 20067711]
[12]
Faria, A.; Monteiro, R.; Azevedo, I.; Calhau, C. Pomegranate juice effects on cytochrome P450S expression: in vivo studies. J. Med. Food, 2007, 10(4), 643-649.
[http://dx.doi.org/10.1089/jmf.2007.403] [PMID: 18158835]
[13]
Saruwatari, A.; Okamura, S.; Nakajima, Y.; Narukawa, Y.; Takeda, T.; Tamura, H. Pomegranate juice inhibits sulfoconjugation in Caco-2 human colon carcinoma cells. J. Med. Food, 2008, 11(4), 623-628.
[http://dx.doi.org/10.1089/jmf.2007.0050] [PMID: 19053852]
[14]
van der Logt, E.M.; Roelofs, H.M.J.; Nagengast, F.M.; Peters, W.H.M. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis, 2003, 24(10), 1651-1656.
[http://dx.doi.org/10.1093/carcin/bgg117] [PMID: 12869420]
[15]
González-Sarrías, A.; Azorín-Ortuño, M.; Yáñez-Gascón, M.J.; Tomás-Barberán, F.A.; García-Conesa, M.T.; Espín, J.C. Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1. J. Agric. Food Chem., 2009, 57(12), 5623-5632.
[http://dx.doi.org/10.1021/jf900725e] [PMID: 19469472]
[16]
Hidaka, M.; Okumura, M.; Fujita, K.; Ogikubo, T.; Yamasaki, K.; Iwakiri, T.; Setoguchi, N.; Arimori, K. Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metab. Dispos., 2005, 33(5), 644-648.
[http://dx.doi.org/10.1124/dmd.104.002824] [PMID: 15673597]
[17]
Nagata, M.; Hidaka, M.; Sekiya, H.; Kawano, Y.; Yamasaki, K.; Okumura, M.; Arimori, K. Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Drug Metab. Dispos., 2007, 35(2), 302-305.
[http://dx.doi.org/10.1124/dmd.106.011718] [PMID: 17132763]
[18]
Ibrahim, Z.S.; El-Shazly, S.A.; Ahmed, M.M.; Soliman, M.M. Effects of Pomegranate on Drug Metabolizing Cytochrome P450 Enzymes Expressions in Rats. Glob. Vet., 2016, 16(5), 481-490.
[19]
Bishayee, A.; Bhatia, D.; Thoppil, R.J.; Darvesh, A.S.; Nevo, E.; Lansky, E.P. Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis, 2011, 32(6), 888-896.
[http://dx.doi.org/10.1093/carcin/bgr045] [PMID: 21389260]
[20]
James, M.O.; Sacco, J.C.; Faux, L.R. Effects of food natural products on the biotransformation of PCBs. Environ. Toxicol. Pharmacol., 2008, 25(2), 211-217.
[http://dx.doi.org/10.1016/j.etap.2007.10.024] [PMID: 19255595]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 1
Year: 2021
Published on: 11 December, 2020
Page: [89 - 93]
Pages: 5
DOI: 10.2174/1872312814999201211203314
Price: $65

Article Metrics

PDF: 425
HTML: 2